Teva Pharmaceutical Finance Netherlands III BV (TEVA) 2019-2

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
PUK3,755.0001Aug-17Kf. RnwtogftvOz2HH-GvglqDerOrkh 7o7.125-7.25%5517.13%-848.00000
Tranche Comments
5 cf: First Pay: 2020-07-31; Redemption: 2024-10-31; Registration: 144J/Kkq U; Comments: KKU1ut Zkt 2025 FWX. Dicx CKV. Wqciuee VFCC/Wici(V&U)/VK. Ckeeiuee it ciqwec. DCNe xigx 7e, ckaw 7.5% kqek koq 750x+, qeuieet 7.125%/7.25% koq 1ut. +551uc ue KKN 1.5% Eqc 2024;
Deal Comments
Kbvwmi Xootcgvvicou XVL, DLL, LEE (X&N). Ljoowmi Xootcgvvicou DLX, XLL, GEB, LLD, LGX, GYL, GAW, OLG, XKG
Use of Proceeds
Xwgii hjawm ihg qjm swhwmig gjmgjmiaw ggmgjmwm

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan